|
 嚴重急性呼吸道症候群病毒之B細胞抗原決定位及其胜肽抗原(SARS-COV-SPECIFIC B-CELL EPITOPE AND APPLICATIONS THEREOF )
|
刊登日期：2014/05/21 |
|
|
|
|
|
| ‧ 專利名稱 |
嚴重急性呼吸道症候群病毒之B細胞抗原決定位及其胜肽抗原(SARS-COV-SPECIFIC B-CELL EPITOPE AND APPLICATIONS THEREOF ) |
| ‧ 專利證書號 |
US 7,740,858 B2
|
| ‧ 專利權人 |
國立臺灣大學 |
‧ 專利國家
(申請日) |
美國 (2004/09/21)
|
|
|
| |
| ‧ 發明人/PI |
吳漢忠,劉怡如,邱倩玉,
|
| ‧ 單位 |
口腔生物科學研究所(獨立至牙醫專業學院)
|
| ‧ 簡歷/Experience |
|
|
| 技術摘要 / Our Technology： |
Disclosed is SARS-CoV-specific B-cell epitope and applications thereof. The epitopes are peptides and can either be expressed in phages or synthesized to diagnose SARS patients accurately. High sensitivity and specificity of the serologic detection are achievable by using a plurality of SARS-CoV-specific B-cell epitope-based peptides. Therefore, the peptides can be applied to SARS diagnosis and have potentials to be immunogens for producing antibodies against SARS.
|
| 專利簡述 / Intellectual Properties： |
|
| |
聯繫方式 / Contact： |
| 臺大產學合作總中心 / Center of Industry-Academia Collaboration, NTU |
|
| Email：ordiac@ntu.edu.tw |
電話/Tel：02-3366-9945 |
|
|
| |
|
| |
 |
專利行銷平台